​

ALX Oncology Ownership | Who Owns ALX Oncology?


OverviewForecastFinancialsChartTranscripts

ALX Oncology Ownership Summary


ALX Oncology is owned by 77.73% institutional investors, 0.89% insiders, and 21.37% retail investors. Tcg crossover management is the largest institutional shareholder, holding 24.25% of ALXO shares. HBM Healthcare Investments AG Ord is the top mutual fund, with 6.21% of its assets in ALX Oncology shares.

ALXO Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockALX Oncology77.73%0.89%21.37%
SectorHealthcare Stocks 247.07%12.15%-159.22%
IndustryBiotech Stocks 385.89%11.79%-297.68%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Tcg crossover management13.01M24.25%$26.09M
Ra capital management13.01M24.25%$26.09M
Venbio partners12.88M24.01%$25.83M
Redmile group7.96M14.84%$15.97M
Blackstone5.83M10.86%$11.71M
Driehaus capital management5.73M10.69%$11.50M
Almitas capital3.17M5.91%$6.36M
5am venture management3.06M5.70%$6.13M
Blackrock funding, inc. /de7.71M5.69%$10.72M
Blackrock2.69M5.36%$16.21M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Venbio partners12.88M9.21%$25.83M
5am venture management3.06M1.70%$6.13M
Almitas capital3.17M1.44%$6.36M
Silverarc capital management6.57M1.07%$9.13M
Redmile group7.96M1.06%$15.97M
Caxton20.95K1.05%$29.11K
Tcg crossover management13.01M0.75%$26.09M
Ra capital management13.01M0.28%$26.09M
Orbimed advisors2.87M0.11%$5.75M
Driehaus capital management5.73M0.08%$11.50M

Top Buyers

HolderShares% AssetsChange
Ra capital management13.01M0.28%13.01M
Tcg crossover management13.01M0.75%13.01M
Blackstone5.83M0.05%5.83M
Redmile group7.96M1.06%4.70M
Driehaus capital management5.73M0.08%4.31M

Top Sellers

HolderShares% AssetsChange
Vestal point capital, lp---3.60M
Vivo capital---3.18M
Tang capital management---3.16M
Cormorant asset management, lp---3.14M
Adage capital partners gp---2.00M

New Positions

HolderShares% AssetsChangeValue
Tcg crossover management13.01M0.75%13.01M$26.09M
Ra capital management13.01M0.28%13.01M$26.09M
Blackstone5.83M0.05%5.83M$11.71M
5am venture management3.06M1.70%3.06M$6.13M
Orbimed advisors2.87M0.11%2.87M$5.75M

Sold Out

HolderChange
Srs capital advisors-2.00
Allspring global investments-2.00
Creekmur asset management-4.00
Farther finance advisors-4.00
Gamma investing-12.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 20269836.11%105,438,93411.85%770.96%6953.33%10-
Mar 31, 202634-45.16%9,343,336-68.01%170.59%15-37.50%9-43.75%
Dec 31, 202511-82.54%2,731,277-90.17%50.19%4-76.47%2-93.75%
Sep 30, 202518-71.43%2,395,272-91.76%40.15%4-80.00%8-75.00%
Jun 30, 202563-26.74%29,075,912-13.08%541.38%20-39.39%3210.34%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
HBM Healthcare Investments AG Ord8.59M6.21%-5.45K
Vanguard Morn Total Stk Mkt Idx Investor3.64M2.71%-
Vanguard Total Stock Mkt Idx Inv3.64M2.71%-
Vanguard MStar Total Stk Mkt Idx Invest3.64M2.63%-
Vanguard US Total Market Shares ETF984.59K1.84%-
iShares Russell 2000 ETF2.54M1.84%-
Fidelity Select Biotechnology835.50K1.58%-
Fidelity Stock Selector Small Cap837.11K1.57%10.71K
Fidelity Series Small Cap Opps769.53K1.44%-
Fidelity Small Cap Value Fund678.40K1.29%-

Recent Insider Transactions


DateNameRoleActivityValue
Aug 17, 2026Lettmann Jason CHIEF EXECUTIVE OFFICERSell$4.30K
Aug 17, 2026Wong Shelly SVP, FINANCE AND CAOSell$1.11K
Jul 01, 2026Wong Shelly SVP, FINANCE AND CAOSell$2.86K
Mar 19, 2026Lettmann Jason CHIEF EXECUTIVE OFFICERSell$26.71K
Mar 19, 2026Pinto Shelly SVP, FINANCE AND CAOSell$1.96K

Insider Transactions Trends


DateBuySell
2026 Q3-3
2026 Q2--
2026 Q114
2025 Q4--
2025 Q333

ALXO Ownership FAQ


Who Owns ALX Oncology?

ALX Oncology shareholders are primarily institutional investors at 77.73%, followed by 0.89% insiders and 21.38% retail investors. The average institutional ownership in ALX Oncology's industry, Biotech Stocks , is 385.89%, which ALX Oncology falls below.

Who owns the most shares of ALX Oncology?

ALX Oncology’s largest shareholders are Tcg crossover management (13.01M shares, 24.25%), Ra capital management (13.01M shares, 24.25%), and Venbio partners (12.88M shares, 24.01%). Together, they hold 72.51% of ALX Oncology’s total shares outstanding.

Does Blackrock own ALX Oncology?

Yes, BlackRock owns 5.36% of ALX Oncology, totaling 2.69M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 16.21M$. In the last quarter, BlackRock increased its holdings by 466.06K shares, a 20.98% change.

Who is ALX Oncology’s biggest shareholder by percentage of total assets invested?

Venbio partners is ALX Oncology’s biggest shareholder by percentage of total assets invested, with 9.21% of its assets in 12.88M ALX Oncology shares, valued at 25.83M$.

Who is the top mutual fund holder of ALX Oncology shares?

HBM Healthcare Investments AG Ord is the top mutual fund holder of ALX Oncology shares, with 6.21% of its total shares outstanding invested in 8.59M ALX Oncology shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools